-
CXO head companies plan to build new bases overseas to accelerate the process of pharmaceutical innovation
Time of Update: 2022-08-15
[PharmaNet Corporate News] WuXi AppTec, the leading CXO company, recently announced that the company plans to establish a R&D and production base in Singapore, and expects to invest a total of 2 billion Singapore dollars (about 1.
-
The performance of this pharmaceutical company has skyrocketed, and its net profit in the first half of 2022 will increase by more than 20,000%
Time of Update: 2022-08-15
. As for the reasons for the changes in performance in the first half of this year, Jiu'an Medical explained in the announcement that the company's iHealth kit products have obtained the FDA EUA authorization in the United States, and the company's own brand "iHealth" is used through the website of the US subsidiary and Amazon's US e-commerce platform.
-
Blockbuster drugs face patent cliff, and this multinational pharmaceutical company is accelerating acquisitions
Time of Update: 2022-08-15
[Pharmaceutical News] Recently, Merck and Orion announced that they have reached a global research and development cooperation agreement to jointly develop Orion's investigational therapy ODM-208 and other drugs targeting cytochrome P450 11A1 (CYP11A1), which is a steroid synthesis.
-
The prevention and control of cardiovascular and cerebrovascular diseases cannot be relaxed for a moment!
Time of Update: 2022-08-15
Zhongyuan Oilfield Health Hut Lvde Real Estate Health Hut [Pharmaceutical Network Enterprise News] After the summer, the temperature rises suddenly, the heat is unbearable, and cardiovascular and cerebrovascular diseases have also entered a period of high incidence .
-
Another drug of Hengrui has been approved for clinical trials, and the company has received good news since June
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] On June 15, Hengrui Pharmaceutical issued an announcement that the company's SHR4640 tablets obtained the "Drug Clinical Trial Approval Notice" approved and issued by the State Food and Drug Administration.
-
The pace of global commercialization of this pharmaceutical company's innovative drugs continues to accelerate!
Time of Update: 2022-08-15
Development, production and commercialization interests in 17 countries in the Middle East and North Africa, including the United Arab Emirates, Saudi Arabia, Egypt, Kuwait, Oman, Bahrain, [Pharmaceutical Network Enterprise News] Recently, Huadong Medicine announced that it has reached a strategic cooperation with Gulf Pharmaceutical Industries PJSC (JULPHAR) (hereinafter referred to as "Julphar"), a Middle Eastern company.
-
Pick up before 12:00am and deliver before 7:00pm!
Time of Update: 2022-08-15
Hardware equipment, in order to respond to the surge in demand for traditional Chinese medicine and improve the efficiency and quality of traditional Chinese medicine preparation, Taiyang Shukang Pharmaceutical introduced the intelligent dispensing system of Donghua original traditional Chinese medicine, allowing the intelligent dispensing method to further enhance the service capacity of traditional Chinese medicine Taiyang Shukang Pharmaceutical Decoction Center was completed and put into operation in 2015.
-
This pharmaceutical company accounted for one-fifth of the 16 large-scale mergers and acquisitions in the first half of the year
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] In order to cope with problems such as the imminent expiration of original research drugs, patent cliffs, intensified competition in the industry, and declining profits of generic drugs, many large pharmaceutical companies in recent years have begun to strengthen their research and development pipelines through continuous mergers and acquisitions.
-
Du Fu Instrument Factory has been recognized and affirmed, and won the "June Pharmaceutical Network Enterprise Live Broadcasting Award"!
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] Recently, Zhengzhou Dufu Instrument Factory (hereinafter referred to as: Dufu Instrument Factory) participated online in the zyzhan June pharmaceutical machin
-
good news!
Time of Update: 2022-08-15
By strengthening the research and development and innovation of core technologies, with advanced production equipment, strict quality management, and more thoughtful services, it will improve and develop together with pharmaceutical manufacturers!Looking forward to the future, Bolang Machinery said that it will continue to make progress.
-
Renfu Pharmaceutical's new indication for remazolam besylate for injection is approved, which will bring positive impact to the company
Time of Update: 2022-08-15
. It is reported that in addition to the approval of the new indications of remazolam besylate for injection recently, Renfu Medicine, the company's holding subsidiary, Yichang Renfu, has also received the "Drug Clinical Application" for RFUS-144 injection approved and issued by the State Drug Administration.
-
Sanofi's Sarclisa combination therapy has significant efficacy in the treatment of multiple myeloma
Time of Update: 2022-08-15
The trial is evaluating the addition of the CD38-targeting antibody Sarclisa (isatuximab) to the proteasome inhibitor Kyprolis (carfilzomib, cardinal) in patients with relapsed multiple myeloma (MM) who have received 1-3 prior anti-myeloma treatments.
-
The new delisting regulations have landed!
Time of Update: 2022-08-15
After the disclosure of the 2021 annual report, more than 40 companies in the Shanghai and Shenzhen stock exchanges have reached a mandatory delisting, setting a record high for A-shares . A few days
-
Good news| Bailinke won the "Excellent Service Provider of Biomedical Industry"
Time of Update: 2022-08-15
It is committed to continuously providing customers with high-quality innovative products and solutions, and creating an efficient, safe and competitive biopharmaceutical supply chain ecosystem ” Bailinke is a high-tech group enterprise that provides process solutions for life sciences, focusing on key process equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell therapy, gene therapy and other biological products.
-
This pharmaceutical company has already reviewed 12 varieties in 2022, and a total of 36 varieties have been selected in the first seven batches of centralized procurement
Time of Update: 2022-08-15
Recently, the good news of the approval of Pemetrexed disodium for injection of Class 4 generic drugs of Kelun Pharmaceutical Co. Pemetrexed disodium for injection is a metabolite with huge market space .
-
NMN can regulate lipid metabolism and improve various chronic diseases caused by obesity
Time of Update: 2022-08-15
Recently, Professor Mika Kivimöki and her team from University College London, UK, based on clinical research data of more than 100,000 people, found that obesity is closely related to 21 diseases such as cardiovascular metabolism, digestion, respiratory, neurological, musculoskeletal and infectious diseases.
-
Sanofi's "Slimming Program" Continues, 17 Drugs Sold
Time of Update: 2022-08-15
[Pharmaceutical Network Enterprise News] In order to better survive and develop in the competition, many pharmaceutical companies are currently focusing on their main business and divesting some busi
-
good news!
Time of Update: 2022-08-15
All products of the company are designed and manufactured according to GMP and FDA standards, and their main technical indicators are at the high level in China Haoming Microwave has always been committed to the development and application of microwave technology and hot air technology in the fields of food, medical treatment, wood, chemical fiber, chemical industry, rubber, ceramics, papermaking, environmental protection, textile and other fields, as well as the production and manufacture of complete sets of equipment.
-
The pharmaceutical company's IPO failed due to unreviewed core products
Time of Update: 2022-08-15
The answer to this question will undoubtedly affect the company's continued profitability In addition to the unreviewed core varieties, the China Securities Regulatory Commission is also concerned about the company's aluminum-magnesium pirin tablets (II) being transferred out of the Sichuan Medical Insurance Catalog.
-
This pharmaceutical equipment company's performance in the first half of the year is positive!
Time of Update: 2022-08-15
Among them, in the pharmaceutical equipment industry, there is also a company that firstly released an announcement of good results from January to June this year, namely Tofflon [Pharmaceutical Network Enterprise News] Recently, listed companies are gradually disclosing their performance forecasts for the first half of 2022.